What is the recommended treatment duration of ampicillin (Ampicillin) for enterococcus bacteremia?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: June 25, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

The recommended treatment duration for ampicillin in enterococcus bacteremia is typically 4-6 weeks of intravenous therapy. This recommendation is based on the most recent and highest quality study available, which suggests that either 4 or 6 weeks of therapy is reasonable for native valve endocarditis (NVE), depending on the duration of symptoms before initiation of therapy 1. For patients with symptoms or prosthetic valve endocarditis (PVE), 6-week therapy is recommended 1.

The standard dosing for adults with normal renal function is 2 grams IV every 4-6 hours. For severe infections, ampicillin is often combined with an aminoglycoside (usually gentamicin) for synergistic effect, particularly for the first 2 weeks of therapy 1. This combination therapy is especially important for endocarditis or other complicated infections.

Some key points to consider when treating enterococcus bacteremia with ampicillin include:

  • The extended duration of therapy is necessary because enterococci are relatively resistant organisms, and adequate treatment time is needed to completely eradicate the infection and prevent relapse.
  • Blood cultures should be repeated during treatment to confirm clearance of the bacteremia.
  • Treatment duration may need to be extended if there are complications such as endocarditis, osteomyelitis, or abscess formation.
  • For patients with penicillin allergies, vancomycin is typically used as an alternative, though susceptibility testing is crucial as some enterococci may be vancomycin-resistant 1.

It's also important to note that the treatment regimen may vary depending on the specific strain of Enterococcus and its susceptibility to different antibiotics, as well as the presence of any underlying conditions or complications 1.

From the Research

Treatment Duration of Ampicillin for Enterococcus Bacteremia

  • The recommended treatment duration of ampicillin for enterococcus bacteremia is not explicitly stated in the provided studies.
  • However, study 2 suggests that bactericidal therapy for enterococcal infections often requires the use of cell wall-active antimicrobial agents in combination with aminoglycosides.
  • Study 3 evaluated the treatment of experimental enterococcal endocarditis and found that daptomycin, vancomycin, and ampicillin-gentamicin combinations were effective in reducing intravegetation enterococcal densities, but the treatment duration was 5 days.
  • Study 4 reported a pilot study of ampicillin-ceftriaxone combination for treatment of orthopedic infections due to Enterococcus faecalis, where patients received ampicillin-ceftriaxone for 25 days (interquartile range, 15 to 34 days), followed by amoxicillin in some cases.
  • It is essential to note that the treatment duration may vary depending on the specific clinical context, the severity of the infection, and the patient's response to treatment, as highlighted in studies 5 and 6.

Key Considerations

  • The choice of antibiotic regimen and treatment duration should be guided by susceptibility testing and clinical experience, as emphasized in study 2.
  • Combination therapy may be necessary to achieve a bactericidal effect, especially in severe infections, as suggested in study 3.
  • Further studies are needed to determine the optimal treatment duration for enterococcus bacteremia, as noted in study 5.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Therapy of enterococcal infections.

European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 1990

Research

Assessing outcomes of adult oncology patients treated with linezolid versus daptomycin for bacteremia due to vancomycin-resistant Enterococcus.

Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners, 2016

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.